{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:48:48Z","timestamp":1794473328648,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Helmholtz Zentrum M\u00fcnchen - Deutsches Forschungszentrum f\u00fcr Gesundheit und Umwelt (GmbH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims\/hypothesis<\/jats:title>\n                <jats:p>The aim of this study was to explore the utility of islet autoantibody (IAb) levels for the prediction of type 1 diabetes in autoantibody-positive children.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Prospective cohort studies in Finland, Germany, Sweden and the USA followed 24,662 children at increased genetic or familial risk of developing islet autoimmunity and diabetes. For the 1403 who developed IAbs (523 of whom developed diabetes), levels of autoantibodies against insulin (IAA), glutamic acid decarboxylase (GADA) and insulinoma-associated antigen-2 (IA-2A) were harmonised for analysis. Diabetes prediction models using multivariate logistic regression with inverse probability censored weighting (IPCW) were trained using 10-fold cross-validation. Discriminative power for disease was estimated using the IPCW concordance index (C index) with 95% CI estimated via bootstrap.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A baseline model with covariates for data source, sex, diabetes family history, HLA risk group and age at seroconversion with a 10-year follow-up period yielded a C index of 0.61 (95% CI 0.58, 0.63). The performance improved after adding the IAb positivity status for IAA, GADA and IA-2A at seroconversion: C index 0.72 (95% CI 0.71, 0.74). Using the IAb levels instead of positivity indicators resulted in even better performance: C index 0.76 (95% CI 0.74, 0.77). The predictive power was maintained when using the IAb levels alone: C index 0.76 (95% CI 0.75, 0.76). The prediction was better for shorter follow-up periods, with a C index of 0.82 (95% CI 0.81, 0.83) at 2 years, and remained reasonable for longer follow-up periods, with a C index of 0.76 (95% CI 0.75, 0.76) at 11 years. Inclusion of the results of a third IAb test added to the predictive power, and a suitable interval between seroconversion and the third test was approximately 1.5 years, with a C index of 0.78 (95% CI 0.77, 0.78) at 10 years follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions\/interpretation<\/jats:title>\n                <jats:p>Consideration of quantitative patterns of IAb levels improved the predictive power for type 1 diabetes in IAb-positive children beyond qualitative IAb positivity status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00125-022-05799-y","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T02:02:31Z","timestamp":1664935351000},"page":"93-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0792-070X","authenticated-orcid":false,"given":"Kenney","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8605-5712","authenticated-orcid":false,"given":"Vibha","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Stavropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6557-270X","authenticated-orcid":false,"given":"Riitta","family":"Veijola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2228-334X","authenticated-orcid":false,"given":"Jorma","family":"Toppari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1417-6050","authenticated-orcid":false,"given":"Marlena","family":"Maziarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6394-7689","authenticated-orcid":false,"given":"Markus","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Waugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte I.","family":"Frohnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-0475","authenticated-orcid":false,"given":"William","family":"Hagopian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6720-2684","authenticated-orcid":false,"given":"Peter","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the T1DI Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"issue":"6","key":"5799_CR1","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2337\/dc15-0101","volume":"38","author":"E Bonifacio","year":"2015","unstructured":"Bonifacio E (2015) Predicting type 1 diabetes using biomarkers. Diabetes Care 38(6):989\u2013996. https:\/\/doi.org\/10.2337\/dc15-0101","journal-title":"Diabetes Care"},{"issue":"23","key":"5799_CR2","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1001\/jama.2013.6285","volume":"309","author":"AG Ziegler","year":"2013","unstructured":"Ziegler AG, Rewers M, Simell O et al (2013) Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309(23):2473\u20132479. https:\/\/doi.org\/10.1001\/jama.2013.6285","journal-title":"JAMA"},{"issue":"10","key":"5799_CR3","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1210\/jc.2019-00421","volume":"104","author":"W Bauer","year":"2019","unstructured":"Bauer W, Veijola R, Lempainen J et al (2019) Age at seroconversion, HLA genotype, and specificity of autoantibodies in progression of islet autoimmunity in childhood. J Clin Endocrinol Metab 104(10):4521\u20134530. https:\/\/doi.org\/10.1210\/jc.2019-00421","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"5799_CR4","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.2337\/dc19-2547","volume":"43","author":"K Vehik","year":"2020","unstructured":"Vehik K, Bonifacio E, Lernmark \u00c5 et al (2020) Hierarchical order of distinct autoantibody spreading and progression to type 1 diabetes in the TEDDY study. Diabetes Care 43(9):2066\u20132073. https:\/\/doi.org\/10.2337\/dc19-2547","journal-title":"Diabetes Care"},{"issue":"8682","key":"5799_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0140-6736(90)90013-U","volume":"335","author":"E Bonifacio","year":"1990","unstructured":"Bonifacio E, Shattock M, Dean BM et al (1990) Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335(8682):147\u2013149. https:\/\/doi.org\/10.1016\/0140-6736(90)90013-U","journal-title":"Lancet"},{"issue":"2","key":"5799_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.2337\/diabetes.53.2.384","volume":"53","author":"P Achenbach","year":"2004","unstructured":"Achenbach P, Warncke K, Reiter J et al (2004) Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 53(2):384\u2013392. https:\/\/doi.org\/10.2337\/diabetes.53.2.384","journal-title":"Diabetes"},{"issue":"7","key":"5799_CR7","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1007\/s00125-012-2523-3","volume":"55","author":"V Parikka","year":"2012","unstructured":"Parikka V, N\u00e4nt\u00f6-Salonen K, Saarinen M et al (2012) Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia 55(7):1926\u20131936. https:\/\/doi.org\/10.1007\/s00125-012-2523-3","journal-title":"Diabetologia"},{"issue":"7","key":"5799_CR8","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s00125-017-4258-7","volume":"60","author":"PM P\u00f6ll\u00e4nen","year":"2017","unstructured":"P\u00f6ll\u00e4nen PM, Lempainen J, Laine A-P et al (2017) Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility. Diabetologia 60(7):1284\u20131293. https:\/\/doi.org\/10.1007\/s00125-017-4258-7","journal-title":"Diabetologia"},{"issue":"11","key":"5799_CR9","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00592-017-1033-7","volume":"54","author":"M K\u00f6hler","year":"2017","unstructured":"K\u00f6hler M, Beyerlein A, Vehik K et al (2017) Joint modeling of longitudinal autoantibody patterns and progression to type 1 diabetes: results from the TEDDY study. Acta Diabetol 54(11):1009\u20131017. https:\/\/doi.org\/10.1007\/s00592-017-1033-7","journal-title":"Acta Diabetol"},{"key":"5799_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jaut.2016.05.010","volume":"72","author":"AK Steck","year":"2016","unstructured":"Steck AK, Dong F, Waugh K et al (2016) Predictors of slow progression to diabetes in children with multiple islet autoantibodies. J Autoimmun 72:113\u2013117. https:\/\/doi.org\/10.1016\/j.jaut.2016.05.010","journal-title":"J Autoimmun"},{"issue":"2","key":"5799_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1172\/JCI119879","volume":"101","author":"P Kulmala","year":"1998","unstructured":"Kulmala P, Savola K, Petersen JS et al (1998) Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. J Clin Invest 101(2):327\u2013336. https:\/\/doi.org\/10.1172\/JCI119879","journal-title":"J Clin Invest"},{"issue":"6","key":"5799_CR12","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2337\/dc10-2088","volume":"34","author":"AK Steck","year":"2011","unstructured":"Steck AK, Johnson K, Barriga KJ et al (2011) Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes. Diabetes Care 34(6):1397\u20131399. https:\/\/doi.org\/10.2337\/dc10-2088","journal-title":"Diabetes Care"},{"issue":"5","key":"5799_CR13","doi-asserted-by":"publisher","first-page":"808","DOI":"10.2337\/dc14-2426","volume":"38","author":"AK Steck","year":"2015","unstructured":"Steck AK, Vehik K, Bonifacio E et al (2015) Predictors of progression from the appearance of islet autoantibodies to early childhood diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY). Diabetes Care 38(5):808\u2013813. https:\/\/doi.org\/10.2337\/dc14-2426","journal-title":"Diabetes Care"},{"issue":"8","key":"5799_CR14","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1210\/jc.2003-031887","volume":"89","author":"JM Barker","year":"2004","unstructured":"Barker JM, Barriga KJ, Yu L et al (2004) Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 89(8):3896\u20133902. https:\/\/doi.org\/10.1210\/jc.2003-031887","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"5799_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1210\/endrev\/bnab013","volume":"42","author":"M So","year":"2021","unstructured":"So M, Speake C, Steck AK et al (2021) Advances in type 1 diabetes prediction using islet autoantibodies: beyond a simple count. Endocr Rev 42(5):584\u2013604. https:\/\/doi.org\/10.1210\/endrev\/bnab013","journal-title":"Endocr Rev"},{"issue":"9","key":"5799_CR16","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.2337\/dc13-0425","volume":"36","author":"JM Sosenko","year":"2013","unstructured":"Sosenko JM, Skyler JS, Palmer JP et al (2013) The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients. Diabetes Care 36(9):2615\u20132620. https:\/\/doi.org\/10.2337\/dc13-0425","journal-title":"Diabetes Care"},{"issue":"1","key":"5799_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2337\/dc21-0878","volume":"45","author":"K Ng","year":"2022","unstructured":"Ng K, Stavropoulos H, Anand V et al (2022) Islet autoantibody type-specific titer thresholds improve stratification of risk of progression to type 1 diabetes in children. Diabetes Care 45(1):160\u2013168. https:\/\/doi.org\/10.2337\/dc21-0878","journal-title":"Diabetes Care"},{"key":"5799_CR18","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.2337\/dc20-1836","volume":"44","author":"V Anand","year":"2021","unstructured":"Anand V, Li Y, Liu B et al (2021) Islet autoimmunity and HLA markers of presymptomatic and clinical type 1 diabetes: joint analyses of prospective cohort studies in Finland, Germany, Sweden, and the U.S. Diabetes Care 44:2269\u20132276. https:\/\/doi.org\/10.2337\/dc20-1836","journal-title":"Diabetes Care"},{"issue":"3","key":"5799_CR19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s001250051616","volume":"44","author":"A Kupila","year":"2001","unstructured":"Kupila A, Muona P, Simell T et al (2001) Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia 44(3):290\u2013297. https:\/\/doi.org\/10.1007\/s001250051616","journal-title":"Diabetologia"},{"issue":"3","key":"5799_CR20","doi-asserted-by":"publisher","first-page":"460","DOI":"10.2337\/diabetes.48.3.460","volume":"48","author":"AG Ziegler","year":"1999","unstructured":"Ziegler AG, Hummel M, Schenker M, Bonifacio E (1999) Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48(3):460\u2013468. https:\/\/doi.org\/10.2337\/diabetes.48.3.460","journal-title":"Diabetes"},{"issue":"8","key":"5799_CR21","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1007\/s00125-005-1813-4","volume":"48","author":"HE Larsson","year":"2005","unstructured":"Larsson HE, Lynch K, Lernmark B et al (2005) Diabetes-associated HLA genotypes affect birthweight in the general population. Diabetologia 48(8):1484\u20131491. https:\/\/doi.org\/10.1007\/s00125-005-1813-4","journal-title":"Diabetologia"},{"issue":"7","key":"5799_CR22","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s001250050514","volume":"39","author":"M Rewers","year":"1996","unstructured":"Rewers M, Bugawan TL, Norris JM et al (1996) Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 39(7):807\u2013812. https:\/\/doi.org\/10.1007\/s001250050514","journal-title":"Diabetologia"},{"key":"5799_CR23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1196\/annals.1288.067","volume":"1005","author":"E Wion","year":"2003","unstructured":"Wion E, Brantley M, Stevens J et al (2003) Population-wide infant screening for HLA-based type 1 diabetes risk via dried blood spots from the public health infrastructure. Ann NY Acad Sci 1005:400\u2013403. https:\/\/doi.org\/10.1196\/annals.1288.067","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"5799_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/s0168-8227(99)00008-x","volume":"44","author":"G Puavilai","year":"1999","unstructured":"Puavilai G, Chanprasertyotin S, Sriphrapradaeng A (1999) Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. Diabetes Res Clin Pract 44(1):21\u201326. https:\/\/doi.org\/10.1016\/s0168-8227(99)00008-x","journal-title":"Diabetes Res Clin Pract"},{"key":"5799_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jbi.2016.03.009","volume":"61","author":"DM Vock","year":"2016","unstructured":"Vock DM, Wolfson J, Bandyopadhyay S et al (2016) Adapting machine learning techniques to censored time-to-event health record data: a general-purpose approach using inverse probability of censoring weighting. J Biomed Inform 61:119\u2013131. https:\/\/doi.org\/10.1016\/j.jbi.2016.03.009","journal-title":"J Biomed Inform"},{"key":"5799_CR26","volume-title":"The elements of statistical learning: data mining, inference, and prediction","author":"T Hastie","year":"2011","unstructured":"Hastie T, Tibshirani R, Friedman J (2011) The elements of statistical learning: data mining, inference, and prediction. Springer, New York"},{"issue":"10","key":"5799_CR27","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/sim.4154","volume":"30","author":"H Uno","year":"2011","unstructured":"Uno H, Cai T, Pencina MJ, D\u2019Agostino RB, Wei LJ (2011) On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med 30(10):1105\u20131117. https:\/\/doi.org\/10.1002\/sim.4154","journal-title":"Stat Med"},{"key":"5799_CR28","doi-asserted-by":"publisher","DOI":"10.1201\/9780429246593","volume-title":"An introduction to the bootstrap","author":"B Efron","year":"1994","unstructured":"Efron B, Tibshirani RJ (1994) An introduction to the bootstrap. CRC Press, Boca Raton, USA. https:\/\/doi.org\/10.1201\/9780429246593"},{"key":"5799_CR29","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A et al (2011) Scikit-learn: machine learning in Python. J Mach Learn Res 12:2825\u20132830","journal-title":"J Mach Learn Res"},{"key":"5799_CR30","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.3737","volume-title":"R: A language and environment for statistical computing","author":"R Development Core Team","year":"2008","unstructured":"R Development Core Team (2008) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/doi.org\/10.2214\/AJR.07.3737"},{"issue":"3","key":"5799_CR31","doi-asserted-by":"publisher","first-page":"662","DOI":"10.2337\/diacare.29.03.06.dc05-0774","volume":"29","author":"S Mrena","year":"2006","unstructured":"Mrena S, Virtanen SM, Laippala P et al (2006) Models for predicting type 1 diabetes in siblings of affected children. Diabetes Care 29(3):662\u2013667. https:\/\/doi.org\/10.2337\/diacare.29.03.06.dc05-0774","journal-title":"Diabetes Care"},{"issue":"3","key":"5799_CR32","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/cei.13360","volume":"198","author":"E Bonifacio","year":"2019","unstructured":"Bonifacio E, Achenbach P (2019) Birth and coming of age of islet autoantibodies. Clin Exp Immunol 198(3):294\u2013305. https:\/\/doi.org\/10.1111\/cei.13360","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"5799_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/1932296814554260","volume":"9","author":"B Sudharsan","year":"2015","unstructured":"Sudharsan B, Peeples M, Shomali M (2015) Hypoglycemia prediction using machine learning models for patients with type 2 diabetes. J Diabetes Sci Technol 9(1):86\u201390. https:\/\/doi.org\/10.1177\/1932296814554260","journal-title":"J Diabetes Sci Technol"},{"key":"5799_CR34","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1161\/CIRCOUTCOMES.116.002797","volume":"9","author":"K Ng","year":"2016","unstructured":"Ng K, Steinhubl SR, deFilippi C, Dey S, Stewart WF (2016) Early detection of heart failure using electronic health records: practical implications for time before diagnosis, data diversity, data quantity, and data density. Circ Cardiovasc Qual Outcomes 9:649\u2013658. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.116.002797","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"5799_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/jamia\/ocw057","volume":"24","author":"BA Goldstein","year":"2017","unstructured":"Goldstein BA, Pencina MJ, Montez-Rath ME, Winkelmayer WC (2017) Predicting mortality over different time horizons: which data elements are needed? J Am Med Inform Assoc 24(1):176\u2013181. https:\/\/doi.org\/10.1093\/jamia\/ocw057","journal-title":"J Am Med Inform Assoc"},{"issue":"5","key":"5799_CR36","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s00125-015-3514-y","volume":"58","author":"JP Krischer","year":"2015","unstructured":"Krischer JP, Lynch KF, Schatz DA et al (2015) The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia 58(5):980\u2013987. https:\/\/doi.org\/10.1007\/s00125-015-3514-y","journal-title":"Diabetologia"},{"issue":"12","key":"5799_CR37","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.2337\/db08-1305","volume":"58","author":"HTA Siljander","year":"2009","unstructured":"Siljander HTA, Simell S, Hekkala A et al (2009) Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population. Diabetes 58(12):2835\u20132842. https:\/\/doi.org\/10.2337\/db08-1305","journal-title":"Diabetes"},{"issue":"10","key":"5799_CR38","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.2337\/dc16-0302","volume":"39","author":"A Fouts","year":"2016","unstructured":"Fouts A, Pyle L, Yu L et al (2016) Do electrochemiluminescence assays improve prediction of time to type 1 diabetes in autoantibody-positive TrialNet subjects? Diabetes Care 39(10):1738\u20131744. https:\/\/doi.org\/10.2337\/dc16-0302","journal-title":"Diabetes Care"},{"issue":"3","key":"5799_CR39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00592-017-1082-y","volume":"55","author":"D Liberati","year":"2018","unstructured":"Liberati D, Wyatt RC, Brigatti C et al (2018) A novel LIPS assay for insulin autoantibodies. Acta Diabetol 55(3):263\u2013270. https:\/\/doi.org\/10.1007\/s00592-017-1082-y","journal-title":"Acta Diabetol"},{"issue":"11","key":"5799_CR40","doi-asserted-by":"publisher","first-page":"e0242049","DOI":"10.1371\/journal.pone.0242049","volume":"15","author":"F de Jesus Cortez","year":"2020","unstructured":"de Jesus Cortez F, Gebhart D, Robinson PV et al (2020) Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR. PLoS One 15(11):e0242049. https:\/\/doi.org\/10.1371\/journal.pone.0242049","journal-title":"PLoS One"},{"key":"5799_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1447.062","volume":"1150","author":"TEDDY Study Group","year":"2008","unstructured":"TEDDY Study Group (2008) The Environmental Determinants of Diabetes in the Young (TEDDY) study. Ann NY Acad Sci 1150:1\u201313. https:\/\/doi.org\/10.1196\/annals.1447.062","journal-title":"Ann NY Acad Sci"},{"issue":"4","key":"5799_CR42","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1001\/jama.2019.21565","volume":"323","author":"A-G Ziegler","year":"2020","unstructured":"Ziegler A-G, Kick K, Bonifacio E et al (2020) Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany. JAMA 323(4):339\u2013351. https:\/\/doi.org\/10.1001\/jama.2019.21565","journal-title":"JAMA"},{"issue":"7","key":"5799_CR43","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.2337\/dc19-2003","volume":"43","author":"RB McQueen","year":"2020","unstructured":"McQueen RB, Geno Rasmussen C, Waugh K et al (2020) Cost and cost-effectiveness of large-scale screening for type 1 diabetes in Colorado. Diabetes Care 43(7):1496\u20131503. https:\/\/doi.org\/10.2337\/dc19-2003","journal-title":"Diabetes Care"},{"key":"5799_CR44","first-page":"668","volume":"2020","author":"BC Kwon","year":"2020","unstructured":"Kwon BC, Achenbach P, Dunne JL et al (2020) Modeling disease progression trajectories from longitudinal observational data. AMIA Annu Symp Proc 2020:668\u2013676","journal-title":"AMIA Annu Symp Proc"},{"issue":"1","key":"5799_CR45","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/s41467-022-28909-1","volume":"13","author":"BC Kwon","year":"2022","unstructured":"Kwon BC, Anand V, Achenbach P et al (2022) Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories. Nat Commun 13(1):1514. https:\/\/doi.org\/10.1038\/s41467-022-28909-1","journal-title":"Nat Commun"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-022-05799-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-022-05799-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-022-05799-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T12:30:01Z","timestamp":1670416201000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-022-05799-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["5799"],"URL":"https:\/\/doi.org\/10.1007\/s00125-022-05799-y","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"assertion":[{"value":"12 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}